{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:41:18Z","timestamp":1793500878255,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018748","name":"argenx nv","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jns.2024.123135","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:28:41Z","timestamp":1721647721000},"page":"123135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets"],"prefix":"10.1016","volume":"463","author":[{"given":"Mathieu F.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dewilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil I.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Muppidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2024.123135_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jns.2024.123135_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21713","article-title":"History of outcome measures for myasthenia gravis","volume":"42","author":"Burns","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2024.123135_bb0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jns.2024.123135_bb0020","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2024.123135_bb0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21016","article-title":"A disease-specific measure of quality of life for myasthenia gravis","volume":"38","author":"Mullins","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2024.123135_bb0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","article-title":"Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.jns.2024.123135_bb0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mus.25198","article-title":"International clinicometric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r","volume":"54","author":"Burns","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2024.123135_bb0040","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2024.123135_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100720200027","article-title":"Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire","volume":"23","author":"Padua","year":"2002","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2024.123135_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/01658107.2019.1660686","article-title":"Preliminary findings of a dedicated ocular myasthenia gravis rating scale: the OMGRate","volume":"44","author":"Wong","year":"2019","journal-title":"Neuroophthalmology"},{"issue":"3","key":"10.1016\/j.jns.2024.123135_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/CND.0000000000000156","article-title":"Outcome measures in myasthenia gravis: incorporation into clinical practice","volume":"18","author":"Muppidi","year":"2017","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2024.123135_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.596382","article-title":"Outcome measures in clinical trials of patients with myasthenia gravis","volume":"11","author":"Thomsen","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2024.123135_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2018.01.006","article-title":"Measuring clinical treatment response in myasthenia gravis","volume":"36","author":"Barnett","year":"2018","journal-title":"Neurol. Clin."},{"issue":"6","key":"10.1016\/j.jns.2024.123135_bb0070","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mus.27476","article-title":"Utilization of MG-ADL in myasthenia gravis clinical research and care","volume":"65","author":"Muppidi","year":"2022","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.jns.2024.123135_bb0075","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pjnns.2017.12.012","article-title":"The myasthenia gravis-specific activities of daily living scale as a useful outcome measure and in routine clinical management in polish patients","volume":"52","author":"Rozmilowska","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jns.2024.123135_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jocn.2021.07.020","article-title":"Evaluation of outcome measures for myasthenia gravis subgroups","volume":"91","author":"Luo","year":"2021","journal-title":"J. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jns.2024.123135_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048198","article-title":"Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)","volume":"11","author":"Berrih-Aknin","year":"2021","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jns.2024.123135_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jns.2024.123135_bb0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","article-title":"MG composite and MG-QOL15 study group. MG-ADL: still a relevant outcome measure","volume":"44","author":"Muppidi","year":"2011","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.jns.2024.123135_bb0100","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"issue":"3","key":"10.1016\/j.jns.2024.123135_bb0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jns.2024.123135_bb0110","series-title":"Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide","year":"2022"},{"issue":"8","key":"10.1016\/j.jns.2024.123135_bb0115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.jns.2024.123135_bb0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","article-title":"A mathematical theory of communication","volume":"27","author":"Shannon","year":"1948","journal-title":"Bell Syst. Tech. J."},{"issue":"5","key":"10.1016\/j.jns.2024.123135_bb0125","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11136-006-9160-6","article-title":"Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon\u2019s indices","volume":"16","author":"Janssen","year":"2007","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jns.2024.123135_bb0130","series-title":"Psychological Testing and Assessment: An Introduction to Tests and Measurement","author":"Cohen","year":"2005"},{"key":"10.1016\/j.jns.2024.123135_bb0135","series-title":"Statistical Power Analysis for the Behavioural Sciences","author":"Cohen","year":"1977"},{"key":"10.1016\/j.jns.2024.123135_bb0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0895-4356(97)00001-2","article-title":"Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis","volume":"50","author":"Vickrey","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jns.2024.123135_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MLR.0b013e31817d92f8","article-title":"Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States","volume":"47","author":"Luo","year":"2009","journal-title":"Med. Care"},{"key":"10.1016\/j.jns.2024.123135_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12955-020-01549-z","article-title":"Gender differences in quality of life among patients with myasthenia gravis in China","volume":"18","author":"Dong","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jns.2024.123135_bb0155","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mus.27331","article-title":"Gender differences in clinical outcomes in myasthenia gravis: aprospective cohort study","volume":"64","author":"Thomsen","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2024.123135_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JND-200484","article-title":"Myasthenia gravis impairment index: sensitivity for change in generalized muscle weakness","volume":"7","author":"de Meel","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2024.123135_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nmd.2013.02.008","article-title":"Performance of individual items of the quantitative myasthenia gravis score","volume":"23","author":"Barnett","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2024.123135_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mus.27837","article-title":"Concordance between patient- and physician-reported MG-ADL scores","volume":"68","author":"Dewilde","year":"2023","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.jns.2024.123135_bb0175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/mus.25764","article-title":"Physician- and self-assessed myasthenia gravis activities of daily living score","volume":"57","author":"Lee","year":"2018","journal-title":"Muscle Nerve"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24002703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24002703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:47:04Z","timestamp":1761785224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24002703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":35,"alternative-id":["S0022510X24002703"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123135","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123135"}}